Objective: The study was aimed to find out the incidence, obstetric risk factors, and various complications of abruptio placentae and to analyze the maternal and perinatal outcome of the same. Materials and Methods: It was a hospital based observational study for a period of one year carried out from 1 st June 2012 to 31 st May 2013. Study population included all pregnancy cases of gestational age of 28 weeks onwards having sign and symptoms of abruptio placentae. Results: Out of 15111 deliveries there were 70 cases of abruptio placentae. The incidence of abruptio placentae was found to be 0.46%. Associated risk factors were anaemia (51.4%), gestational hypertension (37.1%), previous caesarean section (28.6%), polyhydramnios, oligohydramnios etc. Vaginal delivery and caesarean section rates were 58.57% and 41.43% respectively. Eighty percent (80%) babies required NICU and 40% had early neonatal death. Conclusion: Maternal and fetal complications can be minimized provided patients report in time, so that prompt, judicious and definite measures can be undertaken expeditiously and correct treatment instituted.

Objective: To evaluate the role of CRP in clinical outcome in patient of PPROM. Methodology: A prospective study was done on 90 cases with PPROM and raised CRP (>9mg/l) and 90 cases of control group with PPROM and normal CRP (<9mg/l). All mothers and babies were observed from the time of admission to the time of discharge. Results: The incidence of chorioamnionitis was seen to be higher in the cases with raised CRP. The socioeconomic status, parity were found to have an important role in patients developing chorioamnionitis. The sensitivity of the test (raised CRP) in causing clinical chorioamnionitis is more than 90% and specificity in 50%. Odds ratio is 12.5 i.e cases (raised CRP) have 12.5 times more chances of having clinical chorioamnionitis than those of controls (normal CRP). Conclusion: In cases of PPROM, raised CRP is a predictor of clinical chorioamnionitis.